Midlife HTN Tied to Late-Life Cortical Thinning

2011 ◽  
Vol 44 (6) ◽  
pp. 29
Author(s):  
MICHELE G. SULLIVAN
Keyword(s):  
2019 ◽  
Author(s):  
D. Vidal-Pineiro ◽  
N. Parker ◽  
J. Shin ◽  
L. French ◽  
H. Grydeland ◽  
...  

AbstractCortical thinning occurs throughout the entire life and extends to late-life neurodegeneration, yet the neurobiological substrates are poorly understood. Here, we used a virtual-histology technique and gene expression data from the Allen Human Brain Atlas to compare the regional profiles of longitudinal cortical thinning through life (4004 MRIs) with those of gene expression for several neuronal and non-neuronal cell types. The results were replicated in three independent longitudinal datasets. We found that inter-regional profiles of cortical thinning related to expression profiles for marker genes of CA1 pyramidal cells, astrocytes and microglia during development and in aging. During the two stages of life, the relationships went in opposite directions: greater gene expression related to less thinning in development and vice versa in aging. The association between cortical thinning and cell-specific gene expression was also present in mild cognitive impairment and Alzheimer’s Disease. These findings suggest a role of astrocytes and microglia in promoting and supporting neuronal growth and dendritic structures through life that affects cortical thickness during development, aging, and neurodegeneration. Overall, the findings contribute to our understanding of the neurobiology underlying variations in MRI-derived estimates of cortical thinning through life and late-life disease.


Author(s):  
Anand Kumar ◽  
Olusola Ajilore ◽  
Aifeng Zhang ◽  
Daniel Pham ◽  
Virginia Elderkin-Thompson

2017 ◽  
Vol 42 (3) ◽  
pp. 455-461 ◽  
Author(s):  
M E Shaw ◽  
P S Sachdev ◽  
W Abhayaratna ◽  
K J Anstey ◽  
N Cherbuin

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Didac Vidal-Pineiro ◽  
◽  
Nadine Parker ◽  
Jean Shin ◽  
Leon French ◽  
...  

AbstractCortical thinning occurs throughout the entire life and extends to late-life neurodegeneration, yet the neurobiological substrates are poorly understood. Here, we used a virtual-histology technique and gene expression data from the Allen Human Brain Atlas to compare the regional profiles of longitudinal cortical thinning through life (4004 magnetic resonance images [MRIs]) with those of gene expression for several neuronal and non-neuronal cell types. The results were replicated in three independent datasets. We found that inter-regional profiles of cortical thinning related to expression profiles for marker genes of CA1 pyramidal cells, astrocytes and, microglia during development and in aging. During the two stages of life, the relationships went in opposite directions: greater gene expression related to less thinning in development and vice versa in aging. The association between cortical thinning and cell-specific gene expression was also present in mild cognitive impairment and Alzheimer’s Disease. These findings suggest a role of astrocytes and microglia in promoting and supporting neuronal growth and dendritic structures through life that affects cortical thickness during development, aging, and neurodegeneration. Overall, the findings contribute to our understanding of the neurobiology underlying variations in MRI-derived estimates of cortical thinning through life and late-life disease.


2014 ◽  
Vol 22 (5) ◽  
pp. 459-464 ◽  
Author(s):  
Anand Kumar ◽  
Olusola Ajilore ◽  
Aifeng Zhang ◽  
Daniel Pham ◽  
Virginia Elderkin-Thompson

GeroPsych ◽  
2015 ◽  
Vol 28 (2) ◽  
pp. 67-76
Author(s):  
Grace C. Niu ◽  
Patricia A. Arean

The recent increase in the aging population, specifically in the United States, has raised concerns regarding treatment for mental illness among older adults. Late-life depression (LLD) is a complex condition that has become widespread among the aging population. Despite the availability of behavioral interventions and psychotherapies, few depressed older adults actually receive treatment. In this paper we review the research on refining treatments for LLD. We first identify evidence-based treatments (EBTs) for LLD and the problems associated with efficacy and dissemination, then review approaches to conceptualizing mental illness, specifically concepts related to brain plasticity and the Research Domain Criteria (RDoc). Finally, we introduce ENGAGE as a streamlined treatment for LLD and discuss implications for future research.


2001 ◽  
Vol 69 (2) ◽  
pp. 227-239 ◽  
Author(s):  
Kenneth L. Lichstein ◽  
Brant W. Riedel ◽  
Nancy M. Wilson ◽  
Kristin W. Lester ◽  
R. Neal Aguillard
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document